St. Luke's Cancer Center is a clinical research site located in Easton, Pennsylvania, United States 18045.
Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.
St. Luke's Cancer Center has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: Stage III Pancreatic Cancer, Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Oropharynx.
Sponsors: Angiodynamics, Inc., Galera Therapeutics, Inc..
Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
St. Luke's Cancer Center has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
St. Luke's Cancer Center has 2 clinical trials on record, with 1 currently active. Their work covers Stage III Pancreatic Cancer, Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Oropharynx.
St. Luke's Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.